These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Immunologic monitoring of the renal transplant recipient. Suthanthiran M; Garovoy MR Urol Clin North Am; 1983 May; 10(2):315-25. PubMed ID: 6222530 [No Abstract] [Full Text] [Related]
7. D lucus antigen defined lymphoblastoid cell panel allows detection of hitherto undetected adverse presensitization. Suthanthiran M; Fotino M; Cheigh JS; Novogrodsky A; Rubin AL; Stenzel KH Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():199-202. PubMed ID: 386312 [No Abstract] [Full Text] [Related]
8. Evidence for close association between B-cell Fc receptors and Ia antigens, and independence from HLA-A,B locus-determined antigens. Suthanthiran M; Garovoy MR; Fagan G; Gailiunas P; Carpenter CB Transplant Proc; 1977 Dec; 9(4):1705-7. PubMed ID: 304618 [No Abstract] [Full Text] [Related]
9. [Cross test with B-lymphocytes in transplantation immunology]. Laurentaci G; Catalano G; Favoino B; Memeo V; Selvaggi FP; Traficante A Minerva Chir; 1980 May; 35(10):695-9. PubMed ID: 7005723 [TBL] [Abstract][Full Text] [Related]
10. Alloantibodies and outcomes of deceased donor kidney allografts. Cinti P; Pretagostini R; Lai Q; Tamburro ML; Rossi M; Poli L; Berloco P Hum Immunol; 2009 Aug; 70(8):651-4. PubMed ID: 19527761 [TBL] [Abstract][Full Text] [Related]
12. Studies of the antibodies against HLA, Ia-like, Fc, and/or C3 receptors present in pretransplant sera: anti-B-cell antibodies not associated with accelerated graft loss. Soulillou JP; Peyrat MA; Guenel J Transplant Proc; 1978 Jun; 10(2):475-7. PubMed ID: 354139 [No Abstract] [Full Text] [Related]
13. Concomitant immunosuppression and donor-specific transfusions prior to renal transplantation. Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA Transplant Proc; 1989 Feb; 21(1 Pt 2):1828-31. PubMed ID: 2652594 [TBL] [Abstract][Full Text] [Related]
14. T and B cell patterns in irreversibly rejected human renal allografts. Correlation of morphology with surface markers and cytotoxic capacity of the isolated lymphoid infiltrates. Busch GJ; Schamberg JF; Moretz RC; Strom TB; Tilney NL; Carpenter CB Lab Invest; 1976 Sep; 35(3):272-80. PubMed ID: 785094 [TBL] [Abstract][Full Text] [Related]
15. Influence of donor-recipient lymphocyte crossmatch and ABO status on rejection risk in cardiac transplantation. McKenzie FN; Tadros N; Stiller C; Keown P; Sinclair N; Kostuk W Transplant Proc; 1987 Aug; 19(4):3439-41. PubMed ID: 3303513 [No Abstract] [Full Text] [Related]
16. Pretreatment with portal venous ultraviolet B-irradiated donor alloantigen promotes donor-specific tolerance to rat nerve allografts. Genden EM; Mackinnon SE; Yu S; Hunter DA; Flye MW Laryngoscope; 2001 Mar; 111(3):439-47. PubMed ID: 11224773 [TBL] [Abstract][Full Text] [Related]
17. Anti-Ia antibody eluted from rejected human renal allografts. Garovoy MR; Suthanthiran M; Gailiunas P; Carpenter CB; Graves M; Busch G; Tilney NL Transplant Proc; 1978 Sep; 10(3):613-6. PubMed ID: 362645 [No Abstract] [Full Text] [Related]
18. [Comparative evaluation of immunological methods of diagnosing kidney allograft rejection crises]. Drannik GN; Baran EIa; Lukoskaia IG; Tkhor VA Urol Nefrol (Mosk); 1981; (4):18-23. PubMed ID: 7022990 [No Abstract] [Full Text] [Related]
19. Characterization of B-cell and monocyte antibodies in recipient sera and in eluates from rejected kidney allografts. Nunez G; McPhaul J; Stastny P Transplant Proc; 1981 Mar; 13(1 Pt 1):111-3. PubMed ID: 7022807 [TBL] [Abstract][Full Text] [Related]
20. Renal allograft survival in patients with positive donor-specific B lymphocyte crossmatches. Noreen HJ; van der Hagen E; Bach FH; Fryd D; Ascher N; Simmons RL; Najarian JS Transplant Proc; 1987 Feb; 19(1 Pt 1):780-1. PubMed ID: 3274873 [No Abstract] [Full Text] [Related] [Next] [New Search]